by Mark Sheridan | Jan 6, 2021 | Market Flashes
Open Orphan PLC (LSE: ORPH) has recently extended a contract with a top-three global pharma company. Its Venn Life Services subsidiary, operating out of Breda, Netherlands, will provide chemistry, manufacturing, and control consultancy services to support the client’s...
by Mark Sheridan | Dec 23, 2020 | Market Flashes
Open Orphan (LSE: ORPH) subsidiary Venn Life Sciences has extended a consulting contract with a global pharma firm to support two vaccine development programmes. Venn’s Breda office in the Netherlands will handle chemistry, manufacturing and control duties for the...
by Daniel Flynn | Dec 7, 2020 | Market Flashes
Open Orphan’s (LSE:ORPH) strong run continued on Monday morning with the news that it has won two new contracts bolstering its presence in the global fight against coronavirus. The pharmaceutical services company said the first contract awarded to its subsidiary Venn...
by Fiona Shiel | Nov 24, 2020 | Market Flashes
Open Orphan (LSE:ORPH) Tuesday saw pharmaceutical services player Open Orphan (LSE:ORPH) announce the appointment of Elaine Sullivan as a non-executive director to its board. Sullivan is business leader with senior start-up experience, having been a founder of Carrick...
by Patricia Miller | Sep 28, 2020 | Market Flashes
Open Orphan (LSE:ORPH) shot up to record highs on Monday morning after unveiling a £4.3 million contract with a global top ten vaccine company. Shares in the pharmaceutical services player have been steadily moving up this year on the repeated release of a wide...
